Clinical Trials in Colorado

Showing 4261-4280 of 13,761 trials

Vivacit-E Post-market Follow-up Study

NCT03226808

The objectives of this study are to obtain clinical performance (outcomes) data and survivorship for commercially available Vivacit-E (HXPE) liners. This will be done by analysis of polyethylene wear, validated outcome measurement tools, radiographs, and reported adverse events data.

OsteoarthritisAvascular Necrosis of Bone of HipPost-traumatic; Arthrosis+1 more

Zimmer Biomet258 participantsStarted Oct 2013

Parker, Colorado, United States • Chapel Hill, North Carolina, United States • Charlotte, North Carolina, United States +2 more locations

COMPLETEDPhase 144 miles

Study to Measure Cerebrospinal Fluid Mutant Huntingtin Protein in Participants With Early Manifest Stage I or Stage II Huntington's Disease

NCT03664804

The study is designed as a multi-site, prospective, 15-month longitudinal, cohort study measuring CSF mHTT in participants with early manifest Stage I or Stage II Huntington's Disease (HD).

Huntington's Disease

Hoffmann-La Roche95 participantsStarted Dec 2018

Englewood, Colorado, United States • Washington D.C., District of Columbia, United States • Wichita, Kansas, United States +12 more locations

Vivacit-E Post-market Follow-up Study

Study to Measure Cerebrospinal Fluid Mutant Huntingtin Protein in Participants With Early Manifest Stage I or Stage II Huntington's Disease

Find Trials by Condition in Colorado

PATHFINDER 2: a Multi-Cancer Early Detection Study

The WEB-IT Clinical Study

A Phase 2 Study of MP-376 to Prevent Acute Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) Patients

Goals of Care Conversations Study

A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis

A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.

Open-Label, Dose-Escalating Study Assessing Safety, Tolerability, Efficacy, of RP103 in Mitochondrial Disease

VTX958 Versus Placebo for the Treatment of Active Psoriatic Arthritis (Tranquility-PsA)

ANC-501 in the Treatment of Adults With Major Depressive Disorder

Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1)

A Study of Rebastinib (DCC-2036) in Combination With Carboplatin in Patients With Advanced or Metastatic Solid Tumors

Study of Intra-Cardiac Echocardiography in Guiding Left Atrial Appendage Occlusion With the Watchman Device

Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD)

Study to Assess the Safety of DERMASEAL for Diabetic Foot Ulcers

Long-Term Safety Follow-up Study of Cysteamine Bitartrate Delayed-release Capsules (RP103)

The Perceptual Experience of Argus II Users

Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers